Norstrud Andrew James 4
4 · Stem Cell Therapy International, Inc. · Filed Sep 9, 2009
Insider Transaction Report
Form 4
Norstrud Andrew James
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2009-07-27$0.06/sh+1,000,000$59,000→ 1,000,000 total - Award
Common Stock Option
2009-09-04$0.04/sh+900,000$36,000→ 1,300,000 totalExercise: $0.01From: 2009-09-04Exp: 2019-09-04→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]Granted for the relief of compensation owed